<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37366641</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2379-5042</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>mSphere</Title><ISOAbbreviation>mSphere</ISOAbbreviation></Journal><ArticleTitle><i>Akkermansia muciniphila</i> and <i>Lactobacillus plantarum</i> ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota.</ArticleTitle><Pagination><StartPage>e0007023</StartPage><MedlinePgn>e0007023</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00070-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/msphere.00070-23</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE), characterized by persistent inflammation, is a complex autoimmune disorder that affects all organs, challenging clinical treatment. Dysbiosis of gut microbiota promotes autoimmune disorders that damage extraintestinal organs. Modulating the gut microbiome is proposed as a promising approach for fine-running parts of the immune system, relieving systematic inflammation in multiple diseases. This study demonstrated that the administration of <i>Akkermansia muciniphila</i> and <i>Lactobacillus plantarum</i> contributed to an anti-inflammatory environment by decreasing IL-6 and IL-17 and increasing IL-10 levels in the circulation. The treatment of <i>A. muciniphila</i> and <i>L. plantarum</i> restored the intestinal barrier integrity to a different extent. In addition, both strains reduced the deposit of IgG in the kidney and improved renal function significantly. Further studies revealed distinct remodeling roles of <i>A. muciniphila</i> and <i>L. plantarum</i> administration on the gut microbiome. This work demonstrated essential mechanisms of how <i>A. muciniphila</i> and <i>L. plantarum</i> remodel gut microbiota and regulate the immune responses in the SLE mice model. IMPORTANCE Several pieces of research have demonstrated that certain probiotic strains contribute to regulating excessive inflammation and restoring tolerances in the SLE animal model. More animal trials combined with clinical studies are urgently needed to further elucidate the mechanisms for the effect of specific probiotic bacteria in preventing SLE symptoms and developing novel therapeutic targets. In this study, we explored the role of <i>A. muciniphila</i> and <i>L</i>. <i>plantarum</i> in ameliorating the SLE disease activity. Both <i>A. muciniphila</i> and <i>L. plantarum</i> treatment relieved the systemic inflammation and improved renal function in the SLE mouse model. We demonstrated that <i>A. muciniphila</i> and <i>L. plantarum</i> contributed to an anti-inflammatory environment by regulating cytokine levels in the circulation, restoring the intestinal barrier integrity, and remodeling the gut microbiome, however, to a different extent.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Guo</LastName><ForeName>Mengchen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathogen Biology-Microbiology Division, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lu</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University , Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Zhongda Hospital, Southeast University , Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathogen Biology-Microbiology Division, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yumin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University , Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xingyin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-8770-3494</Identifier><AffiliationInfo><Affiliation>Department of Pathogen Biology-Microbiology Division, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen of Jiangsu Province and Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-9785-9150</Identifier><AffiliationInfo><Affiliation>Department of Pathogen Biology-Microbiology Division, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen of Jiangsu Province and Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qisha</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-5101-3851</Identifier><AffiliationInfo><Affiliation>Department of Pathogen Biology-Microbiology Division, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen of Jiangsu Province and Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Laboratory Center for Basic Medical Sciences of Nanjing Medical University , Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mSphere</MedlineTA><NlmUniqueID>101674533</NlmUniqueID><ISSNLinking>2379-5042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000647304">Akkermansia muciniphila</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048191" MajorTopicYN="Y">Lactobacillus plantarum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061327" MajorTopicYN="N">Verrucomicrobia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Akkermansia muciniphila</Keyword><Keyword MajorTopicYN="N">Lactobacillus plantarum</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">probiotics</Keyword><Keyword MajorTopicYN="N">renal function</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37366641</ArticleId><ArticleId IdType="pmc">PMC10449527</ArticleId><ArticleId IdType="doi">10.1128/msphere.00070-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. 2020. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol 21:605&#x2013;614. doi:10.1038/s41590-020-0677-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0677-6</ArticleId><ArticleId IdType="pmc">PMC8135909</ArticleId><ArticleId IdType="pubmed">32367037</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Ainsworth HC, Graham DSC, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Alml&#xf6;f JC, Acevedo-V&#xe1;squez EM, Alarc&#xf3;n GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D&#x2019;Alfonso S, Da Silva BM, de la R&#xfa;a Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frosteg&#xe5;rd J, Garc&#xed;a MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kov&#xe1;cs L, Laustrup H, Lauwerys BR, Li Q-Z, Maradiaga-Cece&#xf1;a MA, Mart&#xed;n J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sj&#xf6;wall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusi&#xe9;-Luna T, Vasconcelos C, Vil&#xe1; LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syv&#xe4;nen A-C, R&#xf6;nnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarc&#xf3;n-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ. 2017. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 8:16021. doi:10.1038/ncomms16021</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16021</ArticleId><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. 2016. New insights into the Immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol 12:716&#x2013;730. doi:10.1038/nrrheum.2016.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR. 2018. Sex hormones in acquired immunity and autoimmune disease. Front. Immunol 9:2279. doi:10.3389/fimmu.2018.02279</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02279</ArticleId><ArticleId IdType="pmc">PMC6180207</ArticleId><ArticleId IdType="pubmed">30337927</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, Caricchio R, Buyon JP, Alekseyenko AV, Silverman GJ. 2019. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis 78:947&#x2013;956. doi:10.1136/annrheumdis-2018-214856</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214856</ArticleId><ArticleId IdType="pmc">PMC6585303</ArticleId><ArticleId IdType="pubmed">30782585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Jia X-M, Xu J-Y, Zhao L-D, Ji J-Y, Wu B-X, Ma Y, Li H, Zuo X-X, Pan W-Y, Wang X-H, Ye S, Tsokos GC, Wang J, Zhang X. 2021. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol 73:232&#x2013;243. doi:10.1002/art.41511</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41511</ArticleId><ArticleId IdType="pubmed">33124780</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Wang H, Xu S, Zhuang Y, An J, Su C, Xia Y, Chen J, Xu ZZ, Liu Q, Wang J, Dan Z, Chen K, Luan X, Liu Z, Liu K, Zhang F, Xia Y, Liu X. 2020. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes 11:1758&#x2013;1773. doi:10.1080/19490976.2020.1768644</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1768644</ArticleId><ArticleId IdType="pmc">PMC7524333</ArticleId><ArticleId IdType="pubmed">32507008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, L&#xf3;pez P, Cuervo A, Arboleya S, Duranti S, Turroni F, Gonz&#xe1;lez S, Su&#xe1;rez A, Gueimonde M, Ventura M, S&#xe1;nchez B, Margolles A, Segata N, Bello MGD. 2014. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio 5:e01548-14. doi:10.1128/mBio.01548-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01548-14</ArticleId><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo XM, Edwards MR, Mu Q, Yu Y, Vieson MD, Reilly CM, Ahmed SA, Bankole AA, McBain AJ. 2018. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol 84:e02288-17. doi:10.1128/AEM.02288-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02288-17</ArticleId><ArticleId IdType="pmc">PMC5795066</ArticleId><ArticleId IdType="pubmed">29196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Toral M, Robles-Vera I, Romero M, de la Visitaci&#xf3;n N, S&#xe1;nchez M, O&#x2019;Valle F, Rodriguez-Nogales A, G&#xe1;lvez J, Duarte J, Jim&#xe9;nez R. 2019. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. FASEB J 33:10005&#x2013;10018. doi:10.1096/fj.201900545RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900545RR</ArticleId><ArticleId IdType="pubmed">31173526</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Liao X, Sparks JB, Luo XM, Schloss PD. 2014. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol 80:7551&#x2013;7560. doi:10.1128/AEM.02676-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02676-14</ArticleId><ArticleId IdType="pmc">PMC4249226</ArticleId><ArticleId IdType="pubmed">25261516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardani F, Mahmoudi M, Esmaeili S-A, Khorasani S, Tabasi N, Rastin M. 2018. In vivo study: Th1&#x2013;Th17 reduction in pristane&#x2010;induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics. J Cell Physiol 234:642&#x2013;649. doi:10.1002/jcp.26819</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26819</ArticleId><ArticleId IdType="pubmed">30078223</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddik HA, Bendali F, Gancel F, Fliss I, Spano G, Drider D. 2017. Lactobacillus plantarum and its probiotic and food potentialities. Probiotics Antimicrob Proteins 9:111&#x2013;122. doi:10.1007/s12602-017-9264-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12602-017-9264-z</ArticleId><ArticleId IdType="pubmed">28271469</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabana-Puig X, Mu Q, Lu R, Swartwout B, Abdelhamid L, Zhu J, Prakash M, Cecere TE, Wang Z, Callaway S, Sun S, Reilly CM, Ahmed SA, Luo XM. 2022. Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus-prone MRL/lpr mice. Front Immunol 13:923754. doi:10.3389/fimmu.2022.923754</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.923754</ArticleId><ArticleId IdType="pmc">PMC9368192</ArticleId><ArticleId IdType="pubmed">35967418</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeun J, Kim S, Cho S-Y, Jun H-J, Park H-J, Seo J-G, Chung M-J, Lee S-J. 2010. Hypocholesterolemic effects of Lactobacillus Plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition 26:321&#x2013;330. doi:10.1016/j.nut.2009.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2009.04.011</ArticleId><ArticleId IdType="pubmed">19695834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KM, Jiang ZY, Zheng CT, Wang L, Yang XF. 2014. Effect of Lactobacillus plantarum on diarrhea and intestinal barrier function of young piglets challenged with enterotoxigenic Escherichia coli K88. J Anim Sci 92:1496&#x2013;1503. doi:10.2527/jas.2013-6619</Citation><ArticleIdList><ArticleId IdType="doi">10.2527/jas.2013-6619</ArticleId><ArticleId IdType="pubmed">24492550</ArticleId></ArticleIdList></Reference><Reference><Citation>Szyma&#x144;ski H, Arma&#x144;ska M, Kowalska-Duplaga K, Szajewska H. 2008. Bifidobacterium longum Pl03, Lactobacillus rhamnosus Kl53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion 78:13&#x2013;17. doi:10.1159/000151300</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000151300</ArticleId><ArticleId IdType="pubmed">18701826</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien M, Van Baarlen P, Hooiveld G, Norin E, M&#xfc;ller M, de Vos WM. 2011. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol 2:166. doi:10.3389/fmicb.2011.00166</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2011.00166</ArticleId><ArticleId IdType="pmc">PMC3153965</ArticleId><ArticleId IdType="pubmed">21904534</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L, MICRO-Obes Consortium, Dumas M-E, Rizkalla SW, Dor&#xe9; J, Cani PD, Cl&#xe9;ment K. 2016. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:426&#x2013;436. doi:10.1136/gutjnl-2014-308778</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2014-308778</ArticleId><ArticleId IdType="pubmed">26100928</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nninen A, Toivonen R, P&#xf6;ysti S, Belzer C, Plovier H, Ouwerkerk JP, Emani R, Cani PD, De Vos WM. 2018. Akkermansia muciniphila induces gut microbiota remodelling and controls Islet autoimmunity in NOD mice. Gut 67:1445&#x2013;1453. doi:10.1136/gutjnl-2017-314508</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2017-314508</ArticleId><ArticleId IdType="pubmed">29269438</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K, Luan X, Liu Q, Wang J, Chang X, Snijders AM, Mao J-H, Secombe J, Dan Z, Chen J-H, Wang Z, Dong X, Qiu C, Chang X, Zhang D, Celniker SE, Liu X. 2019. Drosophila histone demethylase KDM5 regulates social behavior through immune control and gut microbiota maintenance. Cell Host Microbe 25:537&#x2013;552. doi:10.1016/j.chom.2019.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.02.003</ArticleId><ArticleId IdType="pmc">PMC6749836</ArticleId><ArticleId IdType="pubmed">30902578</ArticleId></ArticleIdList></Reference><Reference><Citation>Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazzetti B, Federici B, Rabinovich GA, Morelli A. 2003. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124:1381&#x2013;1394. doi:10.1016/s0016-5085(03)00267-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0016-5085(03)00267-1</ArticleId><ArticleId IdType="pubmed">12730878</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y-X, Shao M-J, Qi Q, Xu Y-S, Yang X-Q, Zhu F-H, He S-J, He P-L, Feng C-L, Wu Y-W, Li H, Tang W, Zuo J-P. 2018. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacol Sin 39:1633&#x2013;1644. doi:10.1038/aps.2017.185</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.185</ArticleId><ArticleId IdType="pmc">PMC6289314</ArticleId><ArticleId IdType="pubmed">29849131</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni C, Domeier PP, Wong EB, Khan TN, Elias MJ, Schell SL, Lukacher AE, Cooper TK, Rahman ZSM. 2015. Distinct and synergistic roles of Fc&#x3b3;RIIB deficiency and 129 strain-derived SLAM family proteins in the development of spontaneous germinal centers and autoimmunity. J Autoimmun 63:31&#x2013;46. doi:10.1016/j.jaut.2015.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.06.011</ArticleId><ArticleId IdType="pmc">PMC4564365</ArticleId><ArticleId IdType="pubmed">26162758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Ying Y, Ye J, Chen M, Wu Q, Dou H, Ni W, Xu H, Xu J. 2021. AAV2-mediated and hypoxia response element-directed expression of bFGF in neural stem cells showed therapeutic effects on spinal cord injury in rats. Cell Death Dis 12:274. doi:10.1038/s41419-021-03546-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03546-6</ArticleId><ArticleId IdType="pmc">PMC7960741</ArticleId><ArticleId IdType="pubmed">33723238</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashina Y, Ishizuka N, Ikumi N, Hayashi H, Manabe A, Hirota C, Tabuchi Y, Matsunaga T, Ikari A. 2020. Upregulation of Claudin-7 expression by angiotensin II in colonic epithelial cells of mice fed with NaCl-depleted diets. Int J Mol Sci 21:1442. doi:10.3390/ijms21041442</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041442</ArticleId><ArticleId IdType="pmc">PMC7073026</ArticleId><ArticleId IdType="pubmed">32093310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, Bai Y, Bisanz JE, Bittinger K, Brejnrod A, Brislawn CJ, Brown CT, Callahan BJ, Caraballo-Rodr&#xed;guez AM, Chase J, Cope EK, Da Silva R, Diener C, Dorrestein PC, Douglas GM, Durall DM, Duvallet C, Edwardson CF, Ernst M, Estaki M, Fouquier J, Gauglitz JM, Gibbons SM, Gibson DL, Gonzalez A, Gorlick K, Guo J, Hillmann B, Holmes S, Holste H, Huttenhower C, Huttley GA, Janssen S, Jarmusch AK, Jiang L, Kaehler BD, Kang KB, Keefe CR, Keim P, Kelley ST, Knights D, Koester I, Kosciolek T, Kreps J, Langille MGI, Lee J, Ley R, Liu Y-X, Loftfield E, Lozupone C, Maher M, Marotz C, Martin BD, McDonald D, McIver LJ, Melnik AV, Metcalf JL, Morgan SC, Morton JT, Naimey AT, Navas-Molina JA, Nothias LF, Orchanian SB, Pearson T, Peoples SL, Petras D, Preuss ML, Pruesse E, Rasmussen LB, Rivers A, Robeson MS, Rosenthal P, Segata N, Shaffer M, Shiffer A, Sinha R, Song SJ, Spear JR, Swafford AD, Thompson LR, Torres PJ, Trinh P, Tripathi A, Turnbaugh PJ, Ul-Hasan S, van der Hooft JJJ, Vargas F, V&#xe1;zquez-Baeza Y, Vogtmann E, von Hippel M, Walters W, Wan Y, Wang M, Warren J, Weber KC, Williamson CHD, Willis AD, Xu ZZ, Zaneveld JR, Zhang Y, Zhu Q, Knight R, Caporaso JG. 2019. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37:852&#x2013;857. doi:10.1038/s41587-019-0252-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0252-6</ArticleId><ArticleId IdType="pmc">PMC7015180</ArticleId><ArticleId IdType="pubmed">31341288</ArticleId></ArticleIdList></Reference><Reference><Citation>Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Gl&#xf6;ckner FO. 2013. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41:D590&#x2013;D596. doi:10.1093/nar/gks1219</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1219</ArticleId><ArticleId IdType="pmc">PMC3531112</ArticleId><ArticleId IdType="pubmed">23193283</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisetsky DS, Bossuyt X, Meroni PL. 2019. ANA as an entry criterion for the classification of SLE. Autoimmun Rev 18:102400. doi:10.1016/j.autrev.2019.102400</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102400</ArticleId><ArticleId IdType="pubmed">31639513</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnblom L, Elkon KB. 2010. Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol 6:339&#x2013;347. doi:10.1038/nrrheum.2010.64</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2010.64</ArticleId><ArticleId IdType="pubmed">20440285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D-Y, Chen Y-M, Wen M-C, Hsieh T-Y, Hung W-T, Lan J-L. 2012. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 21:1385&#x2013;1396. doi:10.1177/0961203312457718</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203312457718</ArticleId><ArticleId IdType="pubmed">22892208</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. 2015. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine 72:146&#x2013;153. doi:10.1016/j.cyto.2014.12.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.12.027</ArticleId><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J. 2002. IL-10 regulates murine lupus. J Immunol 169:2148&#x2013;2155. doi:10.4049/jimmunol.169.4.2148</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.4.2148</ArticleId><ArticleId IdType="pubmed">12165544</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner K, Hermann FJ, Schmidbauer K, Talke Y, Rodriguez Gomez M, Schiechl G, Schlossmann J, Br&#xfc;hl H, Anders H-J, Mack M. 2015. IL-3 contributes to development of lupus nephritis in MRL/Ipr mice. Kidney Int 88:1088&#x2013;1098. doi:10.1038/ki.2015.196</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.196</ArticleId><ArticleId IdType="pubmed">26131743</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroz N, Segal MS. 2013. Lupus nephritis and end-stage kidney disease. Am J Med Sci 346:319&#x2013;323. doi:10.1097/MAJ.0b013e31827f4ee3</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0b013e31827f4ee3</ArticleId><ArticleId IdType="pubmed">23370533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lech M, Anders H-J. 2013. The pathogenesis of lupus nephritis. J Am Soc Nephrol 24:1357&#x2013;1366. doi:10.1681/ASN.2013010026</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013010026</ArticleId><ArticleId IdType="pmc">PMC3752952</ArticleId><ArticleId IdType="pubmed">23929771</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejera Segura B, Altab&#xe1;s Gonz&#xe1;lez I, R&#xfa;a-Figueroa I, P&#xe9;rez Veiga N, Del Campo P&#xe9;rez V, Oliv&#xe9;-Marqu&#xe9;s A, Galindo M, Calvo J, Ovalles-Bonilla JG, Fern&#xe1;ndez-Nebro A, Menor-Almagro R, Tomero E, Del Val Del Amo N, Uriarte Isacelaya E, Mart&#xed;nez-Taboada VM, Andreu JL, Boteanu A, Narv&#xe1;ez J, Movasat A, Montilla C, Senabre Gallego JM, Hern&#xe1;ndez-Cruz B, Andr&#xe9;s M, Salgado E, Freire M, Mach&#xed;n Garc&#xed;a S, Moriano C, Exp&#xf3;sito L, P&#xe9;rez Vel&#xe1;squez C, Velloso-Feijoo ML, Cacheda AP, Lozano-Rivas N, Bonilla G, Ar&#xe9;valo M, Jim&#xe9;nez I, Quevedo-Vila V, Manero-Ruiz FJ, Garc&#xed;a de la Pe&#xf1;a Lefebvre P, V&#xe1;zquez-Rodr&#xed;guez TR, Iba&#xf1;ez-Rua J, Cobo-Iba&#xf1;ez T, Pego-Reigosa JM. 2021. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know? Rheumatology 60:5329&#x2013;5336. doi:10.1093/rheumatology/keab401</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab401</ArticleId><ArticleId IdType="pubmed">33950249</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzy M, Edrees A, Okasha H, El Ashmaui A, Ragab G. 2016. Gastrointestinal manifestations in systemic lupus erythematosus. Lupus 25:1456&#x2013;1462. doi:10.1177/0961203316642308</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316642308</ArticleId><ArticleId IdType="pubmed">27055518</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lin J, Xiao L, Zhang X, Zhao L, Wang M, Li L. 2022. Gut microbiota in systemic lupus erythematosus: a fuse and a solution. J Autoimmun 132:102867. doi:10.1016/j.jaut.2022.102867</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102867</ArticleId><ArticleId IdType="pubmed">35932662</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu A, Lv H, Wang H, Yang H, Li Y, Qian J, Anderson R. 2020. Aging increases the severity of colitis and the related changes to the gut barrier and gut microbiota in humans and mice. J Gerontol A Biol Sci Med Sci 75:1284&#x2013;1292. doi:10.1093/gerona/glz263</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glz263</ArticleId><ArticleId IdType="pubmed">32048723</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI. 2020. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol 38:685&#x2013;688. doi:10.1038/s41587-020-0548-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0548-6</ArticleId><ArticleId IdType="pmc">PMC7365738</ArticleId><ArticleId IdType="pubmed">32483366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyttaris VC, Juang Y-T, Tsokos GC. 2005. Immune cells and cytokines in systemic lupus erythematosus: an update. Curr Opin Rheumatol 17:518&#x2013;522. doi:10.1097/01.bor.0000170479.01451.ab</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.bor.0000170479.01451.ab</ArticleId><ArticleId IdType="pubmed">16093827</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A, Gergely P, Nagy G, Koncz A, Banki K. 2004. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol 25:360&#x2013;367. doi:10.1016/j.it.2004.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.05.001</ArticleId><ArticleId IdType="pmc">PMC4034110</ArticleId><ArticleId IdType="pubmed">15207503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha G, Jeevaratnam K. 2020. A novel antibacterial compound produced by Lactobacillus plantarum LJR13 isolated from rumen liquor of goat effectively controls multi-drug resistant human pathogens. Microbiol Res 241:126563. doi:10.1016/j.micres.2020.126563</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micres.2020.126563</ArticleId><ArticleId IdType="pubmed">32798979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhang H, Rehman MU, Mehmood K, Jiang X, Iqbal M, Tong X, Gao X, Li J. 2018. Antibacterial activity of Lactobacillus plantarum isolated from Tibetan yaks. Microbial Pathogenesis 115:293&#x2013;298. doi:10.1016/j.micpath.2017.12.077</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2017.12.077</ArticleId><ArticleId IdType="pubmed">29305183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B-H, Wu S-C, Shen T-L, Hsu Y-Y, Chen C-H, Hsu W-H. 2021. The applications of Lactobacillus plantarum-derived extracellular vesicles as a novel natural antibacterial agent for improving quality and safety in tuna fish. Food Chem 340:128104. doi:10.1016/j.foodchem.2020.128104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2020.128104</ArticleId><ArticleId IdType="pubmed">33010644</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe5;kansson &#xc5;, Andr&#xe9;n Aronsson C, Brundin C, Oscarsson E, Molin G, Agardh D. 2019. Effects of Lactobacillus plantarum and lactobacillus paracasei on the peripheral immune response in children with celiac disease autoimmunity: a randomized, double-blind, placebo-controlled clinical trial. Nutrients 11:1925. doi:10.3390/nu11081925</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11081925</ArticleId><ArticleId IdType="pmc">PMC6723580</ArticleId><ArticleId IdType="pubmed">31426299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W, Lee EJ, Bae I-H, Myoung K, Kim ST, Park PJ, Lee K-H, Pham AVQ, Ko J, Oh SH, Cho E-G. 2020. Lactobacillus plantarum-derived extracellular vesicles induce anti-inflammatory M2 macrophage polarization in vitro. J Extracell Vesicles 9:1793514. doi:10.1080/20013078.2020.1793514</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2020.1793514</ArticleId><ArticleId IdType="pmc">PMC7480564</ArticleId><ArticleId IdType="pubmed">32944181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Chen L, Zhao Y, Wang C, Duan C, Yang G, Niu C, Li S. 2020. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. Appl Microbiol Biotechnol 104:5273&#x2013;5282. doi:10.1007/s00253-020-10633-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-020-10633-9</ArticleId><ArticleId IdType="pubmed">32335723</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. 2008. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol 74:1646&#x2013;1648. doi:10.1128/AEM.01226-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.01226-07</ArticleId><ArticleId IdType="pmc">PMC2258631</ArticleId><ArticleId IdType="pubmed">18083887</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien M, Vaughan EE, Plugge CM, de Vos WM. 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54:1469&#x2013;1476. doi:10.1099/ijs.0.02873-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/ijs.0.02873-0</ArticleId><ArticleId IdType="pubmed">15388697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansaldo E, Slayden LC, Ching KL, Koch MA, Wolf NK, Plichta DR, Brown EM, Graham DB, Xavier RJ, Moon JJ, Barton GM. 2019. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science 364:1179&#x2013;1184. doi:10.1126/science.aaw7479</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw7479</ArticleId><ArticleId IdType="pmc">PMC6645389</ArticleId><ArticleId IdType="pubmed">31221858</ArticleId></ArticleIdList></Reference><Reference><Citation>Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110:9066&#x2013;9071. doi:10.1073/pnas.1219451110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219451110</ArticleId><ArticleId IdType="pmc">PMC3670398</ArticleId><ArticleId IdType="pubmed">23671105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, Ahmed SA, Yuan R, Li L, Cecere TE, Branson DB, Kirby JL, Goswami P, Leeth CM, Read KA, Oestreich KJ, Vieson MD, Reilly CM, Luo XM. 2017. Control of lupus nephritis by changes of gut microbiota. Microbiome 5:73. doi:10.1186/s40168-017-0300-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0300-8</ArticleId><ArticleId IdType="pmc">PMC5505136</ArticleId><ArticleId IdType="pubmed">28697806</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosser EC, Mauri C. 2016. A clinical update on the significance of the gut microbiota in systemic autoimmunity. J Autoimmun 74:85&#x2013;93. doi:10.1016/j.jaut.2016.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.06.009</ArticleId><ArticleId IdType="pubmed">27481556</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S-C, Brown J, Gong M, Ge Y, Zadeh M, Li W, Croker BP, Michailidis G, Garrett TJ, Mohamadzadeh M, Morel L. 2020. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med 12:eaax2220. doi:10.1126/scitranslmed.aax2220</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aax2220</ArticleId><ArticleId IdType="pmc">PMC7739186</ArticleId><ArticleId IdType="pubmed">32641487</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan L, Qi Y, Qu S, Chen X, Li A, Hendi M, Xu C, Wang L, Hou T, Si J, Chen S. 2021. B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling. Gut Microbes 13:1&#x2013;17. doi:10.1080/19490976.2020.1826746</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1826746</ArticleId><ArticleId IdType="pmc">PMC7889144</ArticleId><ArticleId IdType="pubmed">33557671</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng R, Liang H, Zhang Y, Guo J, Miao Z, Shen X, Chen G, Cheng G, Li M, He F. 2020. Contributions of Lactobacillus plantarum PC170 administration on the recovery of gut microbiota after short-term ceftriaxone exposure in mice. Benef Microbes 11:489&#x2013;509. doi:10.3920/BM2019.0191</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2019.0191</ArticleId><ArticleId IdType="pubmed">32811176</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Yang M, Tang L, Wang F, Huang S, Liu S, Lei Y, Wang S, Xie Z, Wang W, Zhao X, Tang B, Yang S. 2022. TLR4 regulates ROR&#x3b3;t+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila. Microbiome 10:98. doi:10.1186/s40168-022-01296-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01296-x</ArticleId><ArticleId IdType="pmc">PMC9235089</ArticleId><ArticleId IdType="pubmed">35761415</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kuczma MP, Szurek EA, Cebula A, Chassaing B, Jung Y-J, Kang S-M, Fox JG, Stecher B, Ignatowicz L. 2020. Commensal Epitopes drive differentiation of Colonic T Regs. Sci Adv
6:eaaz3186. doi: 10.1126/sciadv.aaz3186
</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz3186</ArticleId><ArticleId IdType="pmc">PMC7164940</ArticleId><ArticleId IdType="pubmed">32494613</ArticleId></ArticleIdList></Reference><Reference><Citation>He R, Chen J, Zhao Z, Shi C, Du Y, Yi M, Feng L, Peng Q, Cui Z, Gao R, Wang H, Huang Y, Liu Z, Wang C. 2022. T-cell activation Rho GTPase-activating protein maintains intestinal homeostasis by regulating intestinal T helper cells differentiation through the gut microbiota. Front Microbiol 13:1030947. doi:10.3389/fmicb.2022.1030947</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1030947</ArticleId><ArticleId IdType="pmc">PMC9873376</ArticleId><ArticleId IdType="pubmed">36704549</ArticleId></ArticleIdList></Reference><Reference><Citation>Widhani A, Djauzi S, Suyatna FD, Dewi BE. 2022. Changes in gut microbiota and systemic inflammation after synbiotic supplementation in patients with systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial. Cells 11:3419. doi:10.3390/cells11213419</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11213419</ArticleId><ArticleId IdType="pmc">PMC9658918</ArticleId><ArticleId IdType="pubmed">36359816</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>